Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L10a pseudogene 6 (RPL10AP6) is a human gene classified as a pseudogene, meaning it is a non-functional DNA sequence similar to a functional gene (RPL10A, ribosomal protein L10a), but does not encode an active protein product. There are no established biological functions, disease associations, or therapeutic roles for this pseudogene, and it does not serve as a drug target[5][6]. Context and rationale: - RPL10AP6 is explicitly described as a pseudogene[5][6]. - Pseudogenes do not produce functional proteins and are not direct therapeutic targets. - No evidence of disease relevance, drug interactions, or molecular function is reported for RPL10AP6 in the available data[5][6]. - The canonical functional gene is RPL10A, which encodes a ribosomal protein involved in protein synthesis, but RPL10AP6 itself is not active[1][3][5]. If a functional (protein-coding) ribosomal protein L10a is needed, information on RPL10A (not on RPL10AP6) should be used.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L10a pseudogene 6 (RPL10AP6).